Increased levels of the homodimeric calcium-binding protein, S100A4, have been shown to cause a metastatic phenotype in at least three independent model systems of breast cancer and its presence in carcinoma cells has been shown to be associated with a reduction in the survival of patients suffering from a range of different cancers. S100A4 has been shown to interact in vitro with another member of the S100 family of proteins, S100A1. The purpose of the present study was to find out whether S100A1 could affect S100A4 function. Fluorescence resonance energy transfer was used to show the interaction of S100A4 and S100A1 in living cells and the binding affinities between S100A4 and S100A1 were determined using a biosensor. S100A1 reduced the S100A4 inhibition of nonmuscle myosin A self-association and phosphorylation in vitro. S100A1 reduced S100A4 induced motility and growth in soft agar and metastasis in vivo. The results show for the first time that interactions between different S100 proteins can affect cancer-related activity, and that the presence of S100A1 protein in carcinoma cells might modulate the effect of S100A4 on their metastatic abilities.
Introduction
The presence of the EF-hand-containing calcium-binding protein S100A4 in carcinoma cells has been associated with a poor prognosis in patients with carcinomas of the bladder, colorectum, gall bladder, oesophagus and lung (Kimura et al., 2000; Ninomiya et al., 2001; Davies et al., 2002; Gongoll et al., 2002; Nakamura et al., 2002) . In an archival set of 349 breast cancer patients, less than 20% of patients with S100A4 in their carcinoma cells were alive after 20 years, whereas greater than 90% of patients with less than 1% S100A4 positive carcinoma cells survived over the same period . In model systems, elevated levels of S100A4 confer a metastatic phenotype upon benign rat mammary tumour cells (Davies et al., 1993; Lloyd et al., 1998) and in transgenic mice bearing neu-oncogene-or MMTV-induced primary mammary tumours (Ambartsumian et al., 1996; Davies et al., 1996) . The poor outlook for cancer patients with elevated expression of S100A4 is likely to be due to the ability of S100A4 to induce a metastatic phenotype; however, the mechanism of the strong metastasisinducing properties of S100A4 is not known. S100A4 has been reported to interact with a number of protein targets, at least in vitro, namely nonmuscle tropomyosin (Takenaga et al., 1994) , nonmuscle myosin A heavy chain (Kriajevska et al., 1994; Ford and Zain, 1995) , p53 (Grigorian et al., 2001) , liprin b1 (Kriajevska et al., 2002) and methionine aminopeptidase 2 (Endo et al., 2002) . S100A4 also self-associates to form a homodimer as shown by its NMR structure (Vallely et al., 2002) . However, Wang et al. (2000) and Tarabykina et al. (2000) have shown that S100A4 associates with another S100 protein, S100A1, using the yeast two-hybrid system. It is now shown that S100A1 can antagonize functions of S100A4 in vitro and in vivo.
Results

Preferential association of S100A4 with S100A1
Previous experiments have shown that S100A4 interacts with S100A1 in the yeast two-hybrid system (Wang et al., 2000) . Thus, S100A4 was tested in the yeast two-hybrid system for self-association as well as for interaction with S100A1, S100P or S100A2. b-Galactosidase activities from the yeast cells expressing S100A4/S100A1 fusion proteins ( Figure 1 ) were significantly higher than those expressing S100A4/S100A4, S100A4/S100P and S100A4/S100A2 (all Po0.01, Student's t test) in the yeast two-hybrid system, indicating that stronger interaction of S100A1 with S100A4 occurred in yeast cells and that S100A4 might preferentially bind to S100A1 in other cells.
Binding parameters for the interactions between recombinant S100A4 (rS100A4) and recombinant S100A1 (rS100A1) in vitro in nonfusion form were determined using an optical biosensor, in a buffer containing 0.5 mM calcium. The binding of rS100A4 to immobilized rS100A4 and to immobilized rS100A1 was always homogenous; there was no evidence for the presence of more than one binding site for rS100A4 in rS100A4 or rS100A1. Plots of k on against ligand concentrations yielded straight lines (r ¼ 0.94-0.98) (data not shown). The association rate constant (k ass ) for the interaction between rS100A4 and immobilized rS100A1 in the presence of 0.5 mM Ca The dissociation rate constant of rS100A4 from immobilized rS100A4 calculated over 10 values at different concentrations of rS100A4 (k diss ¼ 0.00870.0005) was similar to that of rS100A4 from immobilized rS100A1 (k diss ¼ 0.00670.001). The affinity calculated from the kinetic parameters for the interaction between rS100A1 and rS100A4 (Kd ¼ 300760 nM) was higher than that for the selfassociation of rS100A4 (Kd ¼ 670780 nM). The equivalent Kd values calculated from the extents of binding observed at equilibrium were 5007140 and 10007300 nM for the interaction between rS100A4 and rS100A1 and for the self-association of rS100A4, respectively, values which are similar to those calculated from the kinetic binding parameters and which demonstrate the internal consistency of the measurements.
Interaction of S100A4 with S100A1 in mammalian cells revealed by fluorescence resonance energy transfer (FRET) That S100A4 and S100A1 interact in mammalian cells was shown by cotransfecting HeLa cells with expression plasmids encoding enhanced cyan fluorescent protein (ECFP)-S100A4 fusion protein and enhanced yellow fluorescent protein (EYFP)-S100A1. A statistically significant reduction (P ¼ 0.0001) in the fluorescence lifetime of the ECFP-S100A4 by fluorescence lifetime imaging was detected in the presence of the EYFP-S100A1 acceptor, but not in the presence of EYFP (Figure 2 ). This result shows that ECFP-S100A4 and EYFP-S100A1 exhibit close contact (o5 nm) in HeLa cells.
S100A4, but not S100A1 interacts with a recombinant fragment of heavy chain of nonmuscle myosin II isoform A Using the optical biosensor, rS100A4 was shown to interact with a 149 amino-acid recombinant fragment of nonmuscle myosin heavy chain A (rNMMHCIIA) (Figure 3 ) as described previously (Chen et al., 2001) . In contrast, rS100A1 exhibited barely detectable interaction with rNMMHCIIA ( Figure 3 ). S100A1 reverses the inhibitory effect of S100A4 on the sedimentation and phosphorylation of rNMMHCIIA In low-salt buffer, rNMMHCIIA exhibits self-association, which can be detected by a loss of rNMMHCIIA from the supernatant following centrifugation, as described in Materials and methods. rS100A4 can partially reverse this self-association, whereas rS100A1 has no effect upon self-association of rNMMHCIIA ( Figure 4) . Preincubation of rS100A4 with increasing concentrations of rS100A1, at least up to an S100A1/ S100A4 ratio of 0.85, reversed the inhibitory effect of rS100A4 on rNMMHCIIA association ( Figure 5 ). S100A4, but not S100A1, inhibited the phosphorylation of rNMMHCIIA in vitro by protein kinase C ( Figure 6 ). When rS100A4 and rS100A1 were preincubated together, the inhibitory effect of rS100A4 on the phosphorylation was partially relieved and the overall phosphorylation of rNMMHCIIA was increased ( Figure 6 , lanes 1-5). S100A1 reduces the motility and anchorage-independent growth of a high S100A4-containing rat mammary cell line
To investigate the possible effect of S100A1 on the activities of S100A4 in vivo, the level of S100A1 was upregulated in S100A1-negative rat mammary cell lines, the low-S100A4 Rama 37 and the high-S100A4 KP1-Rama 37, by transfection of an S100A1-encoding expression vector, as described in Materials and 
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Figure 1 Association of S100A4 with S100 proteins in the yeast two-hybrid system. Yeast cells were transfected with plasmids LexA-S100A1 þ YESTrp2-S100A1 for self-association of S100A1 (A1/A1), with LexA-S100A4 þ YESTrp2-S100A1 for interaction between S100A4 and S100A1 (A4/A1); with LexA-S100A4 þ YESTrp2-S100A4 for self-association of S100A4 (A4/A4); with LexA-S100A4 þ YESTrp2-S100P for interaction between S100A4 and S100P (A4/P); with LexA-S100A4 þ YESTrp2-S100A2 for interaction between S100A4 and S100A2 (A4/A2); with LexA-S100A4 þ YESTrp2 vector as a negative control to check for absence of interaction between S1000A4 and the product of empty YESTrp2 vector (A4/-). The b galactosidase activity, an approximate indicator of the strength of interaction, was determined as described previously (Wang et al., 2000) Association of S100 proteins G Wang et al methods. Clones were picked from the S100A1-transfected KP1-Rama 37 cells (designated KP1-S100A1-1 and KP1-S100A1-2) that expressed a level of S100A1 mRNA which was similar to that of S100A4 mRNA in the same cells. Clones were also isolated from transfected Rama 37 cells (designated Rama 37-S100A1-1 and Rama 37-S100A1-2) that expressed similar levels of S100A1 to that of KP1-S100A1/2 cells, but no S100A4 was detected by Western blotting. Both the parental cell lines, Rama 37 and KP1-Rama 37, and the cells transfected with empty vector (designated Rama 37 V and KP 1 V, respectively), showed undetectable levels of S100A1 ( Figure 7 ). Immunofluorescent staining of the KP1-S100A1-1 cell line showed that all the cells examined expressed both S100A1 and S100A4 and about 90% of the cells examined expressed both S100A1 and S100A4 at similar levels (data not shown). About 5% of cells expressed more S100A1 than S100A4 and about 5% expressed more S100A4 than S100A1 (data not shown). At higher magnification, the immunofluorescence showed that the S100A1 and S100A4 colocalized, mainly in the perinuclear region of the cells and smaller amounts of the proteins colocalized with one another in the cytoplasm (not shown).
Using Boyden chamber assays, the S100A4-expressing KP1-Rama 37 cell line exhibited a higher rate of motility than its parental cell line, Rama 37 (P ¼ 0.0001, Student's t test), whereas the two Rama 37-S100A1 transfectant cell lines, Rama 37-S100A1-1 and Rama 37-S100A1-2, showed similar rates of motility to that of the parental Rama 37 cell line (P ¼ 0.82 and 0.6, respectively, Fisher Exact test, Table 1 ) and vector control cell line, Rama 37V (P ¼ 0.3 and 0.2, respectively, Fisher Exact test, Table 1 ). This suggests that a high level of S100A4, but not S100A1, promotes cell motility. Both KP1-S100A1 cell lines, which express S100A1 and S100A4, showed a significantly lower rate of motility than their parental cell line, KP1-Rama 37 (P ¼ 0.0001) and vector control cell line, KP1V (P ¼ 0.0001), both of which expressed a high level of S100A4, but no S100A1 (Table 1) . These results indicate that upregulated S100A1 reduces the motility associated with upregulated S100A4. The colony-forming abilities in soft agar of the transfected cells and their parental cells were examined. The Rama 37 and Rama 37-S100A1 cells grew poorly in a soft agar assay (not shown). However, KP1-Rama 37 cells showed a much increased capability for colony growth in soft agar than that of its parental cells, Rama 37. This result suggests that upregulation of S100A4 promotes the anchorage-independent growth of Rama 37 cells. The two clones of KP1-S100A1 cells, expressing both S100A1 and S100A4, showed a lower ability to grow in soft agar than the KP1-Rama 37 or KP1V cells, which expressed a high level of S100A4 alone (all P ¼ 0.001, Student's t test), but had a higher ability of anchorage-independent growth (Table 1) than that of Rama 37 cells or Rama 37-S100A1 cells (P ¼ 0.012 and 0.017, respectively). This suggests that upregulation of S100A1 reduced the anchorage-independent growth of the S100A4-containing cells. S100A1 reduces the incidence of metastases induced by S100A4 in a rat mammary tumour model Subcutaneous injections of cell lines, Rama 37V, Rama 37-S100A1-1 and Rama 37-S100A1-2, KP1-Rama 37 and KP1-S100A1-1 and KP1-S100A1-2 into the mammary fat pads of female syngeneic rats yielded primary mammary tumours with incidences ranging from 49 to 71% (Table 1 ), values that were not significantly different from one another (P ¼ 0.05-1.0, Fisher Exact test). Immunocytochemical staining confirmed that the patterns of expression of S100A1 and S100A4 in primary tumours were the same as those of the cell lines injected (data not shown). Animals injected with Rama 37V or Rama 37-S100A1-1 cells produced no metastases, while Rama 37-S100A1-2 cells produced metastases in only 8% of rats injected. However, the rats injected with KP1-Rama 37 cells or KP1 cells transfected with empty expression vector, KP1V, produced metastases in the lungs in 80% of the rats with tumours (Table 1) , highly significantly higher than Rama 37V, Rama 37-S100A1-1 and Rama 37-S100A1-2 (each P ¼ 0.0001, Fisher Exact test). The two clones of S100A4-and S100A1-containing cells, KP1-S100A1-1 and KP1-S100A1-2, produced metastases in the lungs in 21% and 18% of the rats with tumours, respectively, both highly significantly lower than the incidence with the S100A4-positive, S100A1-negative, KP1-Rama 37 cells (both Po0.0001, Fisher Exact test) or KP1V cells (both 0.0001, Fisher Exact test). These results show that Upregulation of S100A1 and S100A4 in rat mammary tumour cell lines. In all, 10 mg of total RNA extracted from parental and transfected cell lines were analysed by Northern blotting (a-c) with 32 P dCTP-labelled probes. Filters were incubated with probes for S100A1 (a), S100A4 (b), b-actin (c). For Western blotting (d-e), 40 mg of total protein from each cell lysate was analysed by SDS 15% PAGE. A mouse anti-human S100A1 monoclonal antibody (DAKO) and rabbit anti-human S100A4 polyclonal antibody (DAKO) were used to detect S100A1 (d) and S100A4 (e) proteins, respectively. Cell lines were KP1-Rama 37, a metastatic S100A4-expressing derivative of Rama 37; KP1-S100A1-1, KP1 cells transfected with an expression vector containing S100A1 cDNA; KP1 vector, KP1 cells transfected with empty expression vector; Rama 37, a benign nonmetastatic cell line which does not express S100A1 or S100A4; Rama 37-S100A1-1, Rama 37 cells transfected with an expression vector containing S100A1 cDNA; Rama 37 vector, Rama 37 cells transfected with empty expression vector Association of S100 proteins G Wang et al the presence of S100A1 reduces the metastasis-forming ability of S100A4.
Some of the primary tumours exhibited invasion of peripheral blocks of striated muscle (Figure 8 ; Table 1 ). The combined incidence of muscle invasion by tumours from the two S100A1-and S100A4-expressing cell lines, KP1-S100A1-1 and KP1-S100A1-2, was significantly less than muscle invasion by the S100A4-positive, S100A1-negative, KP1-Rama 37 cells (P ¼ 0.03, Fisher Exact test) or KP1V cells (P ¼ 0.007, Fisher Exact test) showing that the presence of S100A1 reduces the invasive potential of the S100A4-containing cells.
Normal host muscle cell proliferation, including the proliferation of smaller myoblast-like cells which were identified by staining for myoglobin (Rudland et al., 1984) , was found around the Rama 37-S100A1-and KP1-S100A1-derived tumours, but not around Rama 37V-and KP1-Rama 37-derived tumours (Figure 8 ). The incidence of muscle proliferation in the tumours derived from the two clones of KP1-S100A1 cells (40 and 45%) was significantly higher than in tumours derived from KP1-Rama 37 cells (0%) (P ¼ 0.02 and 0.009, respectively, Fisher Exact test).
Discussion
It has been shown previously Wang et al., 2000) using the yeast two-hybrid system that S100A4 interacts with another S100 protein, S100A1. In the present experiments, the binding affinity of this interaction in vitro, determined using a biosensor assay, shows Kd values in the range for natural biological interactions (nM) and an interaction between S100A4 and S100A1 has been demonstrated in living mammalian cells using FRET techniques. More importantly, a completely novel finding is now made that the presence of S100A1 antagonizes a major biological function of S100A4, that of the induction of metastasis in vivo and associated properties in cultured cells. S100A4 interacts with, and inhibits the self-association of rNMMHCIIA (Kriajevska et al., 1994; Ford and Zain, 1995) , and it has been suggested that S100A4 affects the phosphorylation of a NMMHCIIA fragment by protein kinase C and casein kinase 2 in vitro (Kriajevska et al., 1998 . When tested in vitro, S100A1 significantly and specifically reversed the inhibitory effects of S100A4 on both the self-assembly of a recombinant fragment of NMMHCIIA and its phosphorylation by protein kinase C. S100A1 itself showed no effect on the self-assembly and phosphorylation by PKC of the NMMHCIIA in vitro, suggesting strongly that the effect of S100A1 is not a direct one, but acts by affecting S100A4 function. S100A1 also inhibited biological effects of S100A4 in vivo. Coexpression of S100A1 in cells expressing high levels of S100A4 significantly reduced their rate of motility and invasion. High expression of S100A4 conferred on the Rama 37 cells the transformationassociated property of anchorage-independent growth, which is thought to be important for tumour cell survival in distant organs (Nakanishi et al., 2002) . Coexpression of S100A1 in the S100A4-expressing Rama 37 cells significantly reduced their rate of colony formation in soft agar.
The above results not only show that S100A4 may exert its effect on several major steps in metastasis, thereby greatly enhancing the metastatic abilities of tumour cells, but also that S100A1 has an antagonistic effect on these S100A4 abilities associated with metastasis, contributing to the overall significant reduction by S100A1 of the incidence of S100A4-induced metastasis in the syngeneic rat model. It is important to note that S100A1 by itself did not reduce cell motility, invasion or anchorage-independent growth in vivo but only reduces the effects exerted by S100A4. The absence of a direct inhibitory effect of S100A1 on metastasis itself was not shown, however, such an effect is considered unlikely in view of the absence of a direct inhibitory effect of S100A1 on those in vitro processes associated with metastasis in vivo.
Unexpectedly in these experiments, marked muscle cell proliferation was observed around the primary tumours derived from the S100A1-expressing cells (Rama 37-S100A1 and KP1-S100A1), but was not observed in primary tumours derived from control cell lines, nor in the S100A4-expressing KP1-Rama 37 cells. Although, S100A1 has been found in replicating myoblasts (Sorci et al., 1999) , its presence in muscle cells is associated with the regulation of enhanced 
(T) invading muscle cells (M). (c) Primary tumour of Rama 37 cells transfected with S100A1 (Rama 37-S100A1) shows the tumour (T) associated with proliferating muscle cells (arrows). (d) Primary tumour of KP1 cells transfected with S100A1 (KP1-S100A1) showing small myoblast-like cells (arrows) close to the tumour cells (T). All panels show staining with antimyoglobin antibody as described in Materials and methods. Bars ¼ 200 mM
Association of S100 proteins G Wang et al contractile performance of the muscle (Most et al., 2001 (Most et al., , 2003 . The present results suggest that S100A1, but not S100A4, produced by the tumour cells could stimulate muscle proliferation and there are several possible explanations for this effect. However, the previously reported extracellular activity of some S100 proteins, notably the neuronal S100B, which is neurotrophic for cultured glial cells and astrocytes (Selinfreund et al., 1991) , raises the possibility that S100A1 might exert its effect extracellularly on host muscle cells in vivo.
Recently, extracellular S100A1 has been reported to inhibit apoptosis in ventricular cardiomyocytes (Most et al., 2003) . In the present system in vivo, S100A1, but not S100A4, stimulates host muscle cell proliferation in the vicinity of the primary tumours. Interestingly, the incidence of host muscle proliferation around KP1-S100A1-derived tumours was significantly reduced relative to that around Rama 37-S100A1-derived tumours (P ¼ 0.01, Fisher Exact test, mean of duplicate clones of each), suggesting that the presence of S100A4 might antagonize the effect of S100A1 on host muscle cells in vivo. Thus, S100A1 and S100A4 are mutually antagonistic towards each others' activities in vivo. How might S100A1 and S100A4 exert their mutually antagonistic effects on one another? The inhibitory effects of S100A1 on S100A4 activity are unlikely to be mediated by the interaction of S100A1 with an S100A4 target, such as NMMHCIIA, since it has been shown using the optical biosensor that S100A1 does not interact directly with the S100A4-binding, rNMMHCIIA fragment (Figure 4 ). Previous studies Wang et al., 2000) and this paper show that S100A1 interacts with S100A4 in vitro and in vivo. It is not clear whether the interaction between S100A1 and S100A4 is due to the formation of heterodimers. On the one hand, determination of the three-dimensional structure of S100A4 (Vallely et al., 2002) and S100A1 has shown that both of these proteins form homodimers. On the other hand, it is well known that S100A1 forms heterodimers with some other S100 proteins, for example with S100B (Donato, 2001 c Motility assay using the Boyden Chamber. Each cell line was subjected to at least three independent experiments. Motility is the mean percentage of cells that moved through the filter in a period of 20 h against the total number of cells seeded in a 24-well plate and cultured in the same medium under the same conditions as that used in the upper chamber (Materials and methods). The mean %7standard deviation (s.d.) are shown. KP1-Rama 37 and KP1V possess similar rates of motility (P ¼ 0.2, Student's t test), but significantly higher than that of Rama 37 or Rama 37V (P ¼ 0.0001 and 0.0002, respectively, Student's t test). KP1-S100A1-1, KP1-S100A1-2, Rama 37-S100A1-1 and Rama 37-S100A1-2 have similar motility rates to those of Rama 37 (P ¼ 0.27, 0.15, 0.82, 0.6, respectively, Student's t test) or Rama 37V (P ¼ 0.07, 0.09, 0.3 and 0.2, respectively, Student's t test), but significantly lower than those of KP1-Rama 37 or KP1V (both P ¼ 0.0001). The colony-forming ability in soft agar. Cells (2 Â 10 4 ) were seeded in a 35 mm culture dish. Each cell line was subjected to at least three independent experiments. After 4 weeks of routine culture, colonies with diameter larger than 0.06 mm were counted under the microscope. Rama 37, Rama 37V and Rama 37-S100A1 cells did not form any colonies in soft agar. The two cell lines of KP1-S100A1-1 and -2 formed similar numbers of colonies/field (P ¼ 0.35, Student's t test) but significantly fewer colonies/field than that of KP1-Rama 37 or KP1V cells (both P ¼ 0.001, Student's t test).
e Number of tumours/number of animals inoculated. Tumour incidence of the transfected cells was not significantly different from the Rama 37V cells (P ¼ 0.05-1.0, Fisher Exact test).
f Number of animals with lung metastases/number of animals with tumours. There was no significant difference in the incidence of metastasis between the two separate clones of Rama 37-S100A1 (P ¼ 0.39, Fisher Exact test) or between the two clones of KP1-S100A1 (P ¼ 1.0) or between KP1-Rama 37 and KP1V (P ¼ 1.0). However, KP1-S100A1-1 and KP1-S100A1-2 have a significantly lower incidence of metastases than KP1-Rama 37 (both Po0.0001, Fisher Exact test) or KP1V (Po0.0001 and P ¼ 0.0001, respectively, Fisher Exact test). g Numbers of animals with muscle invasion/numbers of animals with tumours surrounded by muscle. No difference was found in the incidence of muscle invasion between tumours from the two Rama 37-S100A1 clones (P ¼ 0.72, Fisher Exact test) or between tumours from the two KP1-S100A1 clones (P ¼ 0.67, Fisher Exact test) or between tumours from KP1-Rama 37 and KP1V (P ¼ 1.0, Fisher Exact test). Tumours from Rama 37-S100A1-1 and Rama 37-S100A1-2 exhibited no significant differences in invasion of muscle from Rama 37V (P ¼ 1.0 and 0.68, respectively, Fisher Exact test). KP1-S100A1-1 and KP1-S100A1-2 tumours combined were significantly different from KP1-Rama 37 (P ¼ 0.03, Fisher Exact test), and KP1V (P ¼ 0.007, Fisher Exact test).
h Number of animals with muscle cell proliferation/number of animals with tumours surrounded by muscle (samples without any muscle tissue evident on the sections were excluded). In those tumours that exhibited muscle associated with the tumour, there was significantly more muscle cell proliferation in Rama 37-S100A1-1 or Rama 37-S100A1-2 than in Rama 37V (both Po0.0001, Fisher Exact test). There was significantly more muscle cell proliferation in tumours derived from the two KP1-S100A1 clones than in tumours derived from KP1-Rama 37 (P ¼ 0.02 and 0.009, respectively, Fisher Exact test) or KP1V (P ¼ 0.009 and 0.003, respectively, Fisher Exact test). There were no significant differences between the two Rama 37-S100A1 clones (P ¼ 0.68) or the two KP1-S100A1 clones (P ¼ 1.0). ND, not determined Association of S100 proteins G Wang et al S100A4/S100A1 heterodimers, as well as the homodimers, using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry and subsequently have shown that S100A4 exists in solution as an equilibrium between monomers and homodimers (Tarabykina et al., 2001) . Furthermore, previous studies (Wang et al., 2000) have shown that point mutations in the dimer interfaces of either S100A4 or S100A1 interrupt both homodimerization and the heterodimeric interaction between S100A1 and S100A4, as determined by the yeast two-hybrid system. In the biosensor experiments, it is possible that the observed antagonistic effect of S100A1 protein on S100A4 is due to interactions between homodimeric forms, as no special measures were taken to dissociate the recombinant S100 proteins into their individual subunits, once the recombinant proteins had been mixed. However, the present results report the novel finding that S100 proteins can modulate the activity of others, and this could be a general regulatory mechanism among this family of proteins. The finding that such a regulatory mechanism can affect the function of an S100 protein is likely to be of particular importance to those S100 proteins, such as S100A4 (Gongoll et al., 2002 ) that seem to be involved in human cancer.
Materials and methods
DNA constructs and yeast two-hybrid assay
LexA-S100A4 (bait construct) and YESTrp2-S100A4, YESTrp2-S100A1 and YESTrp2-S100P (prey constructs) were described previously (Wang et al., 2000) . The YESTrp2-S100A2 (bait) construct was constructed as follows. The coding sequence of S100A2 cDNA was amplified by RT-PCR using a 5 0 primer containing a HindIII restriction enzyme site: GCTAAGCTTATGTGCAGTTCTCTGGAG, and a 3 0 primer containing a BamHI restriction enzyme site: GCAGGATCCT CAGGGTCGGTCTGGGCAG. The resultant PCR product was cloned into the HindIII and BamHI sites of YESTrp2 vector. For the yeast two-hybrid system, each pair of bait and prey vectors was delivered into L40 yeast cells by cotransformation and the b-galactosidase activities of the transformants were determined as described before (Becker and Fikes, 1993; Wang et al., 2000) . Results for various pairs of bait and prey were compared by the Student's t test using SPSS software.
Preparation of recombinant proteins
Recombinant S100A4 (rS100A4) and the C-terminal recombinant fragment of nonmuscle myosin II isoform A heavy chain (rNMMHCIIA) were prepared as described previously (Gibbs et al., 1994; Chen et al., 2001) . Recombinant S100A1 protein (S100A1) was expressed in Escherichia coli BL-21 DE3 (Novagen, MD, USA), using a pET11-S100A1 expression plasmid. The plasmid was constructed as follows. The coding sequence of human S100A1 mRNA was amplified by PCR using a 5 0 primer: CTGCGTTTGCATATGGGCTCT-GAGCTGG containing an NdeI site and a 3 0 primer: CGAGGATCCTCAACTGTTCTCGGAGAAG containing a BamH1 site. The resulting PCR product was cut with the restriction enzymes and subcloned into pET11a vector (Novagen, MD, USA). The expression construct was verified by DNA sequencing.
Recombinant S100A1 and S100A4 proteins were purified from E. coli cells as described for S100A4 (Gibbs et al., 1994) . For use as ligates in biosensor assays, the recombinant S100A1 and S100A4 monomeric proteins were further purified using Superdex 75 gel filtration columns. The fractions containing the lower molecular weight proteins were pooled and immediately stored at À801C.
Optical biosensor assay
The purified rS100A4, rS100A1 and rNMMHCIIA proteins were immobilized on aminosilane surfaces (Thermo Electron, Basingstoke, UK) and binding assays were carried out as described previously (Rahmoune et al., 1998a, b; Chen et al., 2001; Wang et al., 2004) . Binding parameters, k on and k off , were calculated using FastFit software (Affinity Sensors) as previously described (Rahmoune et al., 1998a, b; Chen et al., 2001) .
FRET
The S100A1 coding sequence was amplified by PCR using a 5 0 primer: 5 0 -CCGCAAGCTTCGATGGGCTCTGAGCTG, containing a HindIII site (underlined) and a 3 0 primer: 5 0 -CGCGGATCCTCAACTGTTCTCCCAGAAG, containing a BamHI site using YESTrp2-S100A1 DNA as a template. The S100A4 coding sequence was amplified by PCR using 5 0 primer: 5 0 -CTGTGAAGCTTCGATGGCGAGACCCTTG, containing a HindIII site, and 3 0 primer: 5 0 -CGGGATCCT-CACTTCTTCCGGGGCTC, containing a BamHI site using pJLA602-S100A4 DNA (Gibbs et al., 1994) as a template. The expression vectors, pEYFP-S100A1 and pECFP-S100A4, were constructed by inserting the restriction-enzyme-cut, PCR products of S100A1 and S100A4 coding sequences into pEYFP-C1 and pECFP-C1 vectors (Clontech, Palo Alto, USA) between the HindIII and BamHI sites and checked by automated DNA sequencing. HeLa cells were transiently transfected with the expression plasmids for EYFP-S100A1 and ECFP-S100A4 fusion proteins. Fluorescence lifetime microscopy (FLIM) images in the time domain from single cells were collected using time-correlated single photon counting (TCSPC) (Pepperkok et al., 1999) as described previously .
Phosphorylation of recombinant fragment of nonmuscle myosin heavy chain by protein kinase C Purified protein kinase C (PKC) (having a-, b-, g-PKC activities) was purchased from Upstate Biotechnology (Charlottesville, USA) and phosphorylation reactions were carried out according to the manufacturer's instructions. In total, 15 ml samples of the reaction mixture were subjected to SDSpolyacrylamide gel electrophoresis (SDS-PAGE). The gel was dried and radioactive phosphorylation signals were recorded on X-ray film overnight.
To test the effect of rS100A1 on the interaction between rS100A4 and rNMMHCIIA phosphorylation, 5 mM rS100A4 was preincubated overnight with 0-10 mM rS100A1 in buffer containing 0.5 mM CaCl 2 at 41C. The mixture was then incubated with rNMMHCIIA at room temperature for 40 min before carrying out phosphorylation reactions and gel separation as above.
Differential sedimentation of rNMMHCIIA in vitro
A semiquantitative centrifugation method to detect the selfassembly of rNMMHCIIA was adapted from Murakami et al. (1995) . rNMMHCIIA (5 mM) was incubated at 41C overnight in imidazole-HCl (pH 7.5), 100 mM NaCl, 2.5 mM MgCl 2 (Bundling Buffer) in a total volume of 100 ml. After centrifugation at 13 600 g for 30 min, 20 ml of the supernatant was analysed by SDS-PAGE and the unassembled rNMMHCIIA molecules remaining in the supernatant were detected by Western blotting using a polyclonal rabbit antiserum to the rNMMHCIIA Cterminal fragment. To test the effect of S100 proteins on S100A4 in the rNMMHCIIA sedimentation assay, 5 mM rS100A4 was preincubated overnight at 41C with 0-5mM rS100A1 in the presence of 0.5 mM CaCl 2 . The mixture was incubated with rNMMHCIIA for 8 h at 41C. Bundling Buffer was added and the mixture incubated overnight at 41C, as described above.
Cell culture and transfection
The rat mammary (Rama) 37 nonmetastatic benign tumourderived cell line (Dunnington et al., 1983) expresses undetectable levels of S100A1 mRNA and protein and barely detectable levels of S100A4 mRNA and protein by Northern and Western blotting, respectively. The KP1-Rama 37 cell line had been derived from the Rama 37 cell line by transfection of cloned S100A4 genomic DNA (Davies et al., 1993) and expresses a high level of S100A4 and undetectable level of S100A1 proteins. Rama cells were cultured as described before (Dunnington et al., 1983) . For generating stably transfected cell lines, the Rama 37 (Dunnington et al., 1983) and KP1-Rama 37 (Davies et al., 1993) cell lines were transfected with pCDNA-S100A1 or empty pCDNA vectors using lipofectamine (Invitrogen, Paisley, Scotland), and the transfected cells were selected with 750 mg/ml Zeocin. Surviving clones were isolated and transferred to a multiwell dish using a ring cloning technique (Dunnington et al., 1983) and grown under selective conditions for 7 days. The resulting transfected cell lines were designated as follows: Rama 37 cells transfected with empty expression vector, R37V; Rama 37 cells transfected with S100A1 expression vector, Rama 37-S100A1-1 and Rama 37-S100A1-2; KP1-Rama 37 cells transfected with empty expression vector, KP1V; KP1-Rama 37 cells transfected with S100A1 expression vector, KP1-S100A1-1 and KP1-S100A1-2.
Northern hybridization for rat b-actin, S100A1 or S100A4 mRNAs was carried out as described previously (Sambrook et al., 1989) . For Western blotting, 50 mg of total protein, lysed using Laemmli buffer (Laemmli, 1970) were separated by SDS 15% PAGE and then electrically blotted onto a PVDF membrane (Millipore, Billerica, USA). The S100A1 and S100A4 proteins were probed using a mouse anti-S100A1 monoclonal antibody (DAKO, Glosrup, Denmark) and a rabbit anti-S100A4 polyclonal antibody (DAKO), respectively.
Migration assay
Migration assays for Rama 37, KP1-Rama 37 and cells transfected with pCDNA-S100A1 were carried out using Boyden Chamber units with 6.5 mm diameter polycarbonate membrane inserts with 8 mm pores (Corning Costar, Acton, USA), as described previously (Jenkinson et al., 2004) with the following modifications. The number of cells seeded in the chamber was 1 Â 10 5 , instead of 2 Â 10 5 and their viabilities were monitored by seeding the same number of cells in a 24-well plate. The incubation time was 20 h instead of 24 h. The total viability is expressed as a percentage ¼ (total number cells migrated to the lower side of the filter in 20 h/total number of viable cells) Â 100%. Statistical analysis was by Student's t test.
Soft agar assay
Each well (35 mm) of a six-well culture dish was coated with 2 ml bottom agar mixture (DMEM, 10% (v/v) FCS, 0.6% (w/ v) agar). After the bottom layer had solidified, 2 ml top agar mixture (DMEM, 10% (v/v) FCS, 0.3% (w/v) agar) was added containing the cells under test and the dishes incubated at 371C in 10% (v/v) CO 2 for 4 weeks. Twice a week, two drops of routine culture medium were added to each dish. The resultant colonies, >0.06 mm in diameter, were counted using a microscope. A cell mass o0.06 mm was dying and too small to be counted as a colony that survived in the semisolid medium. A total of 10 microscopic fields were randomly selected and the average number of clones in each field was calculated. Statistical analysis was by Student's t test.
Tumorigenicity and metastasis
Metastasis assays using a rat model for breast cancer and histology of tissues were carried out as described previously (Dunnington et al., 1983; Davies et al., 1993) . Animals containing microscopically visible metastases of malignant cells in the lungs and blocks of striated muscle infiltrated by malignant cells at the periphery of the primary tumours were scored positive for metastasis and invasion, respectively. Animals that contained no visible muscle blocks bordering the primary tumours were eliminated from the analysis of muscle invasion and muscle proliferation. For analysis of muscle proliferation, the sections containing visible muscle blocks bordering the primary tumours were immunohistochemically stained with antimyoglobin antibody (Sigma, Dorset, UK) as described previously (Rudland et al., 1984 
